Literature DB >> 11405223

Antimicrobial peptides: properties and applicability.

W van 't Hof1, E C Veerman, E J Helmerhorst, A V Amerongen.   

Abstract

All organisms need protection against microorganisms, e. g. bacteria, viruses and fungi. For many years, attention has been focused on adaptive immunity as the main antimicrobial defense system. However, the adaptive immune system, with its network of humoral and cellular responses is only found in higher animals, while innate immunity is encountered in all living creatures. The turning point in the appreciation of the innate immunity was the discovery of antimicrobial peptides in the early eighties. In general these peptides act by disrupting the structural integrity of the microbial membranes. It has become clear that membrane-active peptides and proteins play a crucial role in both the innate and the adaptive immune system as antimicrobial agents. This review is focused on the functional and structural features of the naturally occurring antimicrobial peptides, and discusses their potential as therapeutics.

Mesh:

Substances:

Year:  2001        PMID: 11405223     DOI: 10.1515/BC.2001.072

Source DB:  PubMed          Journal:  Biol Chem        ISSN: 1431-6730            Impact factor:   3.915


  88 in total

1.  Cationic hydrophobic peptides with antimicrobial activity.

Authors:  Margareta Stark; Li-Ping Liu; Charles M Deber
Journal:  Antimicrob Agents Chemother       Date:  2002-11       Impact factor: 5.191

2.  ANTIMIC: a database of antimicrobial sequences.

Authors:  M Brahmachary; S P T Krishnan; J L Y Koh; A M Khan; S H Seah; T W Tan; V Brusic; V B Bajic
Journal:  Nucleic Acids Res       Date:  2004-01-01       Impact factor: 16.971

Review 3.  Antimicrobial peptides: current status and therapeutic potential.

Authors:  Andreas R Koczulla; Robert Bals
Journal:  Drugs       Date:  2003       Impact factor: 9.546

4.  Structure of (KIAGKIA)3 aggregates in phospholipid bilayers by solid-state NMR.

Authors:  Orsolya Toke; R D O'Connor; Thomas K Weldeghiorghis; W Lee Maloy; Ralf W Glaser; Anne S Ulrich; Jacob Schaefer
Journal:  Biophys J       Date:  2004-07       Impact factor: 4.033

5.  Secondary structure and lipid contact of a peptide antibiotic in phospholipid bilayers by REDOR.

Authors:  Orsolya Toke; W Lee Maloy; Sung Joon Kim; Jack Blazyk; Jacob Schaefer
Journal:  Biophys J       Date:  2004-07       Impact factor: 4.033

6.  Controlled Enzymatic Hydrolysis: A New Strategy for the Discovery of Antimicrobial Peptides.

Authors:  Estelle Yaba Adje; Rafik Balti; Didier Lecouturier; Mostafa Kouach; Pascal Dhulster; Didier Guillochon; Naïma Nedjar-Arroume
Journal:  Probiotics Antimicrob Proteins       Date:  2013-09       Impact factor: 4.609

7.  Histatin 5-derived peptide with improved fungicidal properties enhances human immunodeficiency virus type 1 replication by promoting viral entry.

Authors:  Fedde Groot; Rogier W Sanders; Olivier ter Brake; Kamran Nazmi; Enno C I Veerman; Jan G M Bolscher; Ben Berkhout
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

8.  Candidacidal effects of two antimicrobial peptides: histatin 5 causes small membrane defects, but LL-37 causes massive disruption of the cell membrane.

Authors:  Alice L den Hertog; Jan van Marle; Henk A van Veen; Wim Van't Hof; Jan G M Bolscher; Enno C I Veerman; Arie V Nieuw Amerongen
Journal:  Biochem J       Date:  2005-06-01       Impact factor: 3.857

9.  Rational design of alpha-helical antimicrobial peptides with enhanced activities and specificity/therapeutic index.

Authors:  Yuxin Chen; Colin T Mant; Susan W Farmer; Robert E W Hancock; Michael L Vasil; Robert S Hodges
Journal:  J Biol Chem       Date:  2005-01-27       Impact factor: 5.157

10.  Comparable efficacies of the antimicrobial peptide human lactoferrin 1-11 and gentamicin in a chronic methicillin-resistant Staphylococcus aureus osteomyelitis model.

Authors:  Christopher Faber; Hein P Stallmann; D M Lyaruu; Uwe Joosten; Christof von Eiff; Arie van Nieuw Amerongen; Paul I J M Wuisman
Journal:  Antimicrob Agents Chemother       Date:  2005-06       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.